Humana, Eli Lilly And A Major Mining Stock On CNBC's 'Final Trades'

On CNBC’s "Halftime Report Final Trades," Bryn Talkington of Requisite Capital Management named Freeport-McMoRan Inc. FCX, adding that she likes the stock here in the mid-30s.

Freeport-McMoRan reported third-quarter revenue growth of 16.4% year-over-year to $5.82 billion, topping the consensus of $5.41 billion. Adjusted EPS of 39 cents exceeded the consensus estimate of 34 cents.

Stephen Weiss of Short Hills Capital Partners said Humana Inc. HUM was up around 2% on Monday, but it’s "down quite a bit."

Humana reported third-quarter adjusted EPS of $7.78 compared to $7.31 a year ago, beating the consensus of $7.16.

Don’t forget to check out our premarket coverage here

Joseph Terranova of Virtus Investment Partners named Eli Lilly and Company LLY as his final trade.

Eli Lilly reported better-than-expected financial results for the third quarter.

Price Action: Freeport-McMoRan shares gained 0.6% to close at $35.37, while Humana shares gained 2.2% to settle at $487.31on Monday. Eli Lilly gained 4.8% to close at $595.19 during Monday’s session.

Check This Out: Uber, D.R. Horton And 3 Stocks To Watch Heading Into Tuesday

Photo: Shutterstock